DAVID J WIDMYER
Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology VENICE, FL NPI 1396972246
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology FL CVRx Inc. All categories
General Payments — all program years on this page
$2,624.80
- Category: General Payments
- Program years: PY2018–2024
- Record count: 129
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $327.64 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $327.64 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| CVRx Inc. | $178.39 | 1 |
| CALLIDITAS THERAPEUTICS US INC. | $41.92 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $41.42 | 2 |
| OPKO Pharmaceuticals, LLC | $24.01 | 1 |
| Retrophin, Inc. | $21.26 | 1 |
| Alexion Pharmaceuticals, Inc. | $20.64 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086118258 | Bayer Healthcare Pharmaceuticals Inc. | $21.71 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086211135 | Bayer Healthcare Pharmaceuticals Inc. | $19.71 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1094010315 | Alexion Pharmaceuticals, Inc. | $20.64 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1112850940 | OPKO Pharmaceuticals, LLC | $24.01 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1140962728 | CVRx, Inc. | $178.39 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141511647 | CALLIDITAS THERAPEUTICS US INC. | $24.32 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141520737 | CALLIDITAS THERAPEUTICS US INC. | $17.60 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1149876670 | Travere Therapeutics, Inc. | $21.26 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.